Delphi expert consensus on phlebotomy limitations and treatment challenges in HFE -related hemochromatosis
Clinical Hematology International · 26.08.2026 · 8 (3)
DOI: 10.46989/001c.166769 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Hematology International, online erschienen am 26.08.2026. Verfasst von Jeremy Shearman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, South Warwickshire University NHS Foundation Trust and Warwick Medical School, Warwick, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
HFE -related hemochromatosis (HC) is caused by hepcidin dysregulation and is characterized by excessive iron absorption and accumulation in the liver, heart, and endocrine glands, which leads to complications including arthropathy, cirrhosis, and hepatocellular carcinoma. Standard of care (SoC) typically involves phlebotomy, with iron chelators used less frequently. However, these therapies may cause side effects and negatively impact quality of life, making them troublesome for some patients. Using the Delphi methodology, a survey was developed to identify unmet needs and clinical challenges within the current therapeutic landscape of HC, and to establish consensus statements for its management. Consensus was defined as ≥75% agreement. Thirty-two HC specialists from Europe, Australia and the USA responded to the survey. After three rounds of survey refinement, final consensus statements were compiled. The Delphi process identified key unmet needs in HC, including lack of alternatives to phlebotomy, persistent symptoms, and burden related to the use of current SoC. The consensus process helped establish definitions for high phlebotomy treatment burden, intolerance, and suboptimal response to phlebotomy. The process also identified the subgroup of patients overly burdened by phlebotomy. Patient-reported outcomes were considered key to assessing phlebotomy’s impact, although they are rarely measured in clinical practice. The Delphi study highlighted the limitations of phlebotomy, with respondents identifying a high unmet need for patients who cannot be managed with or do not tolerate this approach. The study suggested exploring alternative therapy options for patients who experience high treatment burden or intolerance to phlebotomy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, South Warwickshire University NHS Foundation Trust and Warwick Medical School, Warwick, UK.
- Department of Medicine, Section of Internal Medicine and EuroBloodNet Referral Center, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
- Department of Internal Medicine, University Hospital and University of Zürich, Zürich, Switzerland.
- Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research (WEHI), Melbourne, Australia.
- Liver Institute Northwest, Seattle, Washington, USA.
- Elson S. Floyd College of Medicine, Washington State University, Seattle, Washington, USA.
ORCID-Profile: Jeremy Shearman
Zitieren
APA
Shearman, J., Girelli, D., Schaer, D. J., Pasricha, S. R., Kowdley, K. V., Olynyk, J. K., Kato, G. J., Abraham, S., Benchikh El Fegoun, S., Pollet, C., & Merle, U. (2026). Delphi expert consensus on phlebotomy limitations and treatment challenges in HFE -related hemochromatosis. Clinical Hematology International, 8(3). https://doi.org/10.46989/001c.166769
Vancouver
Shearman J, Girelli D, Schaer DJ, Pasricha SR, Kowdley KV, Olynyk JK, et al. Delphi expert consensus on phlebotomy limitations and treatment challenges in HFE -related hemochromatosis. Clinical Hematology International. 2026;8(3). doi:10.46989/001c.166769
BibTeX
@article{Shearman2026,
author = {Shearman, Jeremy and Girelli, Domenico and Schaer, Dominik J and Pasricha, Sant-Rayn and Kowdley, Kris V and Olynyk, John K and Kato, Gregory J and Abraham, Sonya and Benchikh El Fegoun, Soraya and Pollet, Charlotte and Merle, Uta},
title = {Delphi expert consensus on phlebotomy limitations and treatment challenges in HFE -related hemochromatosis},
journal = {Clinical Hematology International},
year = {2026},
volume = {8},
number = {3},
doi = {10.46989/001c.166769}
}
EUVIMED